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increasingly used for response monitoring and prediction. In 
this study the diagnostic potential of DCE-MRI for treatment 
response assessment in esophageal cancer is investigated. 
Materials and Methods: In 12 patients receiving nCRT, DCE-
MRI studies were performed before treatment (pre), after 8-
13 fractions (per) and 5-7 weeks after completion of nCRT, 
prior to surgery (post). After resection pathologic assessment 
of the tumor regression grade (TRG) was performed following 
the Mandard score. For analysis a distinction was made 
between a group of good responders (GR), defined as pCr 
(TRG 1) or near-pCr (TRG 2), and poor responders (noGR) 
with TRG ≥ 3. The primary tumor was delineated on the T2W 
images before, during and after nCRT. This delineated 
volume was contracted with an isotropic margin of 2 mm to 
account for residual motion and partial volume effects. 
Within this contracted volume mean, median and 75th 
percentile (P75) of the AUC of the contrast agent 
concentration was calculated. Here, the AUC was defined as 
the integral over the concentration curve (60 seconds, 
starting at inflow of contrast agent). 
Results: In 4 patients (33%) pCR was found and a total of 5 
patients (42%) showed a good response. Initial P75 AUC values 
were the same across GR and noGR. Relative changes in 
mean, median and P75 AUC between pre and per treatment 
were all found to be significant across the two groups, while 
the same parameters comparing pre and post treatment were 
not significant. All noGR showed an increase in AUC 
comparing relative changes between pre and per treatment 
(fig. A), while 80% of GR remained similar or decreased. The 
ΔP75 pre-per was found to be most predictive (-6%±29% for 
GR [mean ± SD] vs. 76%±58% for noGR, p=0.005) (fig B). With 
a cut-off value of 17.4% an area under the ROC curve of 0.97, 
sensitivity of 80%, specificity of 100%, positive predictive 
value (PPV) of 100% and a negative predictive value (NPV) of 
88% is found.  
 
 
Conclusions: Semi-quantitative parameters from DCE-MRI 
studies of before and during treatment were used for 
treatment response prediction of esophageal cancer. The 
decrease in AUC found for some GR, might indicate a 
renormalization in vasculature. The treatment-induced 
change in P75 AUC after 8-13 fractions of nCRT compared to 
initial values reached high PPV and sensitivity. Although this 
is a limited number of patients, the use of P75 AUC for 
treatment response assessment, seems promising. In the 
future we will continue to include more patients to verify 
whether DCE-MRI can be used as an accurate treatment 
response assessment for esophageal cancer.  
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Purpose/Objective: Tumor delineation is one of the weakest 
links in the radiotherapy treatment chain. In order to 
improve treatment, more insight into the errors made by 
delineation is needed. In this study, gross tumor volume 
(GTV) delineations on CT, MRI and the automatic 
segmentation on FDG-PET of laryngeal and hypopharyngeal 
squamous cell carcinoma are validated on histopathology. 
Materials and Methods: Twenty-one patients were included 
with a laryngeal or hypopharyngeal tumor (T3/T4). Before 
total laryngectomy/partial pharyngectomy, CT, MRI 
(T1weighted and T2weighted) and FDG-PET images were 
made in radiotherapy positioning mask. The GTV was 
delineated in consensus by 3 experienced observers on CT 
and MRI. FDG-PET was delineated semi-automatically using a 
Gaussian mixed model based threshold. Tumor has been 
delineated by a pathologist on whole-mount hematoxylin and 
eosin stained histopathological sections (intersections of 
approximately 3 mm) and afterwards digitized and 
reconstructed to a 3 dimensional specimen. This 3D specimen 
was then registered to the imaging prior to laryngectomy. 
The GTVs, as delineated on the imaging, were compared with 
the histopathological based tumor delineation in three 
dimensions (figure 1). 
 
 
Results: The margin around the GTV needed to ensure 95% of 
tumor surface coverage was 3 mm (SD 2), 4 mm (SD 2) and 4 
mm (SD 2) for CT, MRI and FDG-PET, respectively. In the 
semi-automatic delineation of FDG-PET, for one case a 
margin of 9 mm was needed, probably due to large necrotic 
parts in the tumor. 
The part of the tumor included in the GTV (sensitivity) 
amounted to 86% (SD 9), 80% (SD 11) and 79% (SD 11) for CT, 
MRI and FDG-PET, respectively.  
The overestimation of the tumor volume, the positive 
predictive value (PPV), on CT, MRI and FDG-PET was found to 
be 53% (SD 14), 59% (SD 13) and 66% (SD 15), respectively. 
Conclusions: The tumor extensions outside the delineated 
GTVs are similar for all modalities, based on the margins 
needed to cover 95% of the tumor surface. FDG-PET has the 
highest PPV; therefore semi-automatic delineation of FDG-
PET can be used as an initial delineation of the GTV. This 
delineation must be reviewed by a physician and, if 
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necessary, modified based on additional information from 
high resolution CT or MRI. 
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Purpose/Objective: Intensity modulated radiotherapy 
treatment planning for sites with many organs-at-risk (OARs) 
is a complex and labor-intensive process, making it hard to 
obtain consistent and high quality plans. As a solution, an 
automatic interactive optimizer (AIO) was developed to be 
used in conjunction with the Eclipse treatment planning 
system. AIO performance was benchmarked against clinical 
plans of 20 head and neck cancer (HNC) patients treated 
recently at our department using volumetric modulated arc 
therapy (RapidArc).  
Materials and Methods: Our institutional approach to HNC 
planning uses 3-4 optimization objectives per OAR, evenly 
placed along the displayed dose-volume histogram (DVH) 
curve. During the optimization process, the planner attempts 
to maintain a fixed distance between the objectives and the 
DVH curve, while weighting factors (optimization priorities) 
are kept constant. AIO scans the optimization window and 
uses color-coding to differentiate between OAR DVH-lines, 
allowing it to automatically adjust the location of 
optimization objectives far more frequently and consistently, 
again using fixed priorities. The summed cost function for all 
OAR objectives is therefore held constant throughout the 
optimization process, allowing the optimizer to balance 
sparing of the included OARs. Because planning target 
volumes (PTVs) are assigned higher priorities than OARs 
during optimization, AIO can gradually push the OAR 
objectives to lower dose values at each iteration without 
underdosing the PTVs. 
AIO plans were compared to clinical plans on the basis of i) 
Mean dose to the oral cavity (Doc), individual and composite 
salivary glands (Dsal) and swallowing muscles (Dswal). ii) 
Boost/elective PTV (PTVB/PTVE) volumes receiving more than 
95% (V95) and less than 107% (V107) of the prescribed dose. A 
head and neck radiation oncologist performed blinded 
evaluation of the clinical and AIO plans.  
Results: Planning results were averaged over all 20 patients 
and are summarized in the Table. Dosimetric parameters in 
the AIO plans differing significantly (two-sided Student t-test) 
from the clinical plans are indicated by ‘†’ in the table. 
Clinically acceptable maximum doses to the brainstem and 
spinal cord were achieved in all plans. AIO reduced Doc, Dsal 
and Dswal by 2.6, 0.8 and 4.3Gy, respectively, while also 
improving PTVB/PTVE V95 and PTVE V107. 19/20 AIO plans 
were judged as the superior plan by the radiation oncologist, 
while quality of the remaining AIO plan was considered 
similar to the clinical plan. AIO only required a single 
optimization of 20-35 minutes, whereas clinical plans could 
have required multiple iterative optimizations. 
 
Conclusions: The present results show that AIO can automate 
treatment planning for complex HNC patients, increasing 
efficiency while improving quality over manually created 
plans. AIO has been clinically implemented at our clinic for 
HNC treatment planning.  
This work was funded by Varian Medical Systems. 
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Purpose/Objective: Dose painting becomes a popular 
strategy to increase tumor local control in radiotherapy. 
However, only a few research centers have developed the 
tools to apply it to patients. Our aim is to develop an 
automatic workflow for dose painting, which is integrated in 
a commercial treatment planning system (TPS).  
Materials and Methods: A set of MATLAB® functions 
(GTVPETCT) are called through scripting from RayStation 
(RaySearch Laboratories, research version 3.99) to segment 
the primary tumor (GTVPET) in 18FDGPET images, using an 
automatic gradient-based method. The user selects the lower 
and upper limits (Gy) for dose escalation. The FDG uptake in 
each voxel is linearly converted to dose (Gy), starting from 
the median uptake to avoid background contamination. 
Optimization can be performed using either a number N of 
sub-volumes (N selected by the user) or directly on the voxel 
scale thanks to a customized function developed with the 
RaySearch research package (C++). The N contours can be 
used to drive the optimizer towards a dose painting by 
number prescription (DPBN) or either to perform sub-volume 
boosting (dose painting by contours) if uniform dose is 
prescribed inside each contour.  
The workflow can be applied for IMRT and proton therapy, 
but in this work we considered only the latter. To ensure 
robustness against setup (and range) errors, two strategies 
are implemented: 1) integration of margins in a dilated 
prescription; and 2) robust optimization, but only for 
contour-driven optimization. Work is in progress to extend 
this feature to voxel-wise optimization. 
Plan quality was assessed with Quality Volume Histograms 
(QVH), where quality (Q) is the ratio of the planned dose to 
the prescribed dose in each voxel. Robustness is evaluated by 
calculating the dose perturbed by setup errors (and range 
errors for protons) gathered in a set of scenarios. 
As an illustration, the workflow was applied to a H&N 
patient, aiming at reproducing a DPBN prescription. Direct 
voxel-wise optimization and 7 non-uniform dose levels were 
used for Proton Pencil Beam Scanning. 
Results: The DPBN prescription was reproduced successfully 
for both contour-driven and voxel-wise optimizations: more 
than 99% of the PTVPET received at least 95% of the prescribed 
dose (VQ=95%>99%) and less than 1% received more than 105% 
(VQ=105%PET achieved perfect target coverage (VQ=95%=100%) and 
slight overdosing (VQ=105%=9%). Dilated prescriptions yield high 
